Align Formate-dependent phosphoribosylglycinamide formyltransferase; 5'-phosphoribosylglycinamide transformylase 2; Formate-dependent GAR transformylase; GAR transformylase 2; GART 2; Non-folate glycinamide ribonucleotide transformylase; Phosphoribosylglycinamide formyltransferase 2; EC 2.1.2.- (characterized)
to candidate WP_054341956.1 Nant_RS12275 formate-dependent phosphoribosylglycinamide formyltransferase
Query= SwissProt::P33221 (392 letters) >NCBI__GCF_001305295.1:WP_054341956.1 Length = 397 Score = 487 bits (1253), Expect = e-142 Identities = 251/390 (64%), Positives = 298/390 (76%), Gaps = 1/390 (0%) Query: 2 TLLGTALRPAATRVMLLGSGELGKEVAIECQRLGVEVIAVDRYADAPAMHVAHRSHVINM 61 T LGT L P ATRV++ G GELGKEV IE QRLGVEVI VDRYA+APAM VAHRSHVI+M Sbjct: 6 TTLGTPLAPHATRVLMCGGGELGKEVVIELQRLGVEVIVVDRYANAPAMQVAHRSHVISM 65 Query: 62 LDGDALRRVVELEKPHYIVPEIEAIATDMLIQLEEEGLNVVPCARATKLTMNREGIRRLA 121 LDG LR ++ELEKP IVPEIEAIATD L++LE EG V+P A A +LTMNREGIRRLA Sbjct: 66 LDGAVLRAIIELEKPDLIVPEIEAIATDTLLELEAEGFTVIPTANAARLTMNREGIRRLA 125 Query: 122 AEELQLPTSTYRFADSESLFREAVADIGYPCIVKPVMSSSGKGQTFIRSAEQLAQAWKYA 181 E L L TS YRFA++ + A+A+IG PC+VKP+MSSSGKGQ+ +++ + +AW YA Sbjct: 126 GETLGLKTSPYRFAETLDEYTAAIAEIGLPCVVKPIMSSSGKGQSTLKTEADINKAWVYA 185 Query: 182 QQGGRAGAGRVIVEGVVKFDFEITLLTVSAVDGVHFCAPVGHRQEDGDYRESWQPQQMSP 241 Q+GGRAG G+VIVEG V FD+EITLLTV G FC P+GH Q DGDYR+SWQPQ MS Sbjct: 186 QEGGRAGQGKVIVEGFVDFDYEITLLTVRHSMGTSFCEPIGHVQVDGDYRQSWQPQAMSA 245 Query: 242 LALERAQEIARKVVLALGGYGLFGVELFVCGDEVIFSEVSPRPHDTGMVTLISQDLSEFA 301 AL A+ A KV ALGG G+FGVELFV GDEV+FSEVSPRPHDTGMVT+ISQDLSEFA Sbjct: 246 AALNAAKAAAIKVTDALGGRGIFGVELFVKGDEVLFSEVSPRPHDTGMVTMISQDLSEFA 305 Query: 302 LHVRAFLGLPVGGIRQYGPAASAVILPQLTSQNVTFDNVQNAVG-ADLQIRLFGKPEIDG 360 LH RA LGLP+ I +GP+AS+VIL + S + F + + A+ Q+RLFGKPE+ G Sbjct: 306 LHARAILGLPIPNIHFHGPSASSVILVEGESTDTRFSGLNEVLATANTQLRLFGKPEVTG 365 Query: 361 SRRLGVALATAESVVDAIERAKHAAGQVKV 390 RR+GV LA AESV A+ AK AAG+VK+ Sbjct: 366 QRRMGVVLARAESVDAAVSIAKEAAGKVKI 395 Lambda K H 0.320 0.136 0.390 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 449 Number of extensions: 18 Number of successful extensions: 2 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 392 Length of database: 397 Length adjustment: 31 Effective length of query: 361 Effective length of database: 366 Effective search space: 132126 Effective search space used: 132126 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.8 bits) S2: 50 (23.9 bits)
This GapMind analysis is from Sep 24 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory